NovaBone Products Receives 501(k) Clearance for Wound Dressing
JACKSONVILLE, Fla.--(BUSINESS WIRE)--NovaBone Products, a leading biologics bone graft device company, has announced 501(k) clearance from the US Food and Drug Administration for collagen wound dressings.
“These new products illustrate that we are actively engaged in developing collagen products”
The products receiving clearance and now available for the dental industry are NovaTape™ and NovaPlug™. These are the first 100% collagen devices developed by NovaBone Products. The new products are for soft tissue indications and are based on NovaBone’s ongoing research and development success in utilizing collagen. Both products are specifically for the management of oral wounds and sores, including dental sores, oral ulcers (non-infected or viral), periodontal surgical wounds, suture sites, burns, extraction sites, surgical and traumatic wounds.
NovaTape™ and NovaPlug™ follow the company’s recent 501(k) clearance for NovaBone Bone Graft Strip™ and MacroFORM™, both collagen graft devices and represent a significant milestone in NovaBone’s success in developing a line of intuitively-designed collagen devices.
“These new products illustrate that we are actively engaged in developing collagen products,” said Art Wotiz, President of NovaBone Products. “We will continue to pursue additional collagen devices using our regenerative medicine technology and core competencies in designing bioactive medical devices that meet the demands of surgeons.”
In total, NovaBone Products provides seven devices within the field of orthopedics and six for dental indications providing the medical community with unparalleled versatility and the widest range of choices in bioactive graft devices.
NovaBone is a privately held company based in Florida, USA since 2002 and developed the first bioactive synthetic bone graft offered to the orthopaedic community.